发明名称 |
Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
摘要 |
Biomarkers are provided that predict whether a subject having endometrial cancer will or will not respond to a therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof (e.g., lenvatinib mesylate). The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for and treating a subject having, suspected of having, or at risk of developing an endometrial cancer. |
申请公布号 |
AU2014266223(A1) |
申请公布日期 |
2015.11.26 |
申请号 |
AU20140266223 |
申请日期 |
2014.05.12 |
申请人 |
EISAI R&D MANAGEMENT CO., LTD. |
发明人 |
FUNAHASHI, YASUHIRO;KADOWAKI, TADASHI;SACHDEV, PALLAVI |
分类号 |
G01N33/574 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|